What is the share price of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) today?
The share price of SHREEGANES as on 11th March 2025 is ₹0.99. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) share?
The past returns of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) share are- Past 1 week: 4.17%
- Past 1 month: -12.28%
- Past 3 months: -11.61%
- Past 6 months: -12.39%
- Past 1 year: -23.26%
- Past 3 years: -84.41%
- Past 5 years: -84.77%
What are the peers or stocks similar to Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES)?
The peers or stocks similar to Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) include:What is the market cap of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) is ₹39.46 Cr as of 11th March 2025.What is the 52 week high and low of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) share?
The 52-week high of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) is ₹1.44 and the 52-week low is ₹0.83.What is the PE and PB ratio of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) stock?
The P/E (price-to-earnings) ratio of Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) is 62.64. The P/B (price-to-book) ratio is 0.63.Which sector does Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) belong to?
Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) belongs to the Consumer Staples sector & Agro Products sub-sector.How to buy Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) shares?
You can directly buy Shree Ganesh Bio-Tech (India) Ltd (SHREEGANES) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Shree Ganesh Bio-Tech (India) Ltd
SHREEGANESShree Ganesh Bio-Tech (India) Ltd
SHREEGANES
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹39 cr, stock is ranked 3,646
Moderate RiskStock is 2.97x as volatile as Nifty
0.990.00% (+0.00)
0.990.00% (+0.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 20.99 | 0.63 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.92 | 8.99 | 1.61% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The Company produces, processes and markets hybrids of crops, such as corn, sunflower, cotton and grain sorghum etc. It is also engaged in commercial production of large cardamom, banana (G9), teak plant & ginger.
Peers
Compare with peersGODREJAGRO
PE Ratio
39.85
1Y Return
45.45%
Buy Reco %
80.00
PE Ratio
14.20
1Y Return
46.33%
Buy Reco %
100.00
PE Ratio
79.07
1Y Return
10.75%
Buy Reco %
—
CROPSTER
PE Ratio
160.51
1Y Return
26.84%
Buy Reco %
—
SANSTAR
PE Ratio
24.65
1Y Return
21.52%
Buy Reco %
—
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.16 | 8.54 | 7.86 | 5.87 | 2.47 | 17.21 | 72.69 | 63.01 | 21.34 | 25.77 | ||||||||||
Raw Materials | 0.05 | 4.02 | 3.37 | 3.36 | 1.58 | 16.33 | 68.84 | 59.63 | 20.03 | 23.89 | ||||||||||
| Power & Fuel Cost | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.17 | 0.10 | 0.10 | 0.09 | 0.06 | 0.08 | 0.25 | 0.22 | 0.18 | |||||||||||
| Selling & Administrative Expenses | 0.12 | 0.06 | 0.29 | 0.28 | 0.30 | 0.09 | 0.11 | 0.45 | 0.26 | |||||||||||
| Operating & Other expenses | 1.07 | 0.57 | 0.60 | 0.35 | 0.30 | 0.28 | -0.00 | 0.01 | 0.01 | |||||||||||
EBITDA | 0.71 | 3.77 | 3.50 | 1.79 | 0.23 | 0.43 | 3.49 | 2.70 | 0.86 | 1.88 | ||||||||||
| Depreciation/Amortization | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | 0.64 | 3.77 | 3.50 | 1.79 | 0.23 | 0.43 | 3.49 | 2.70 | 0.86 | 1.88 | ||||||||||
| Interest & Other Items | 0.07 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | 0.57 | 3.74 | 3.50 | 1.79 | 0.23 | 0.43 | 3.49 | 2.70 | 0.86 | 1.88 | ||||||||||
| Taxes & Other Items | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.97 | 0.68 | 0.23 | — | ||||||||||
| Net Income | 0.56 | 3.74 | 3.50 | 1.79 | 0.23 | 0.32 | 2.52 | 2.02 | 0.63 | 1.88 | ||||||||||
| EPS | 0.01 | 0.05 | 0.09 | 0.08 | 0.01 | 0.01 | 0.06 | 0.05 | 0.02 | 0.05 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Consumer StaplesAgro Products
Compare valuation on Screener
Consumer StaplesAgro Products
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Shree Ganesh Bio-Tech (India) Ltd | 62.64 | 0.63 | — |
| Godrej Agrovet Ltd | 39.85 | 4.91 | 1.34% |
| Gujarat Ambuja Exports Ltd | 14.20 | 1.77 | 0.33% |
| Jubilant Agri and Consumer Products Ltd | 79.07 | 8.83 | — |
Price Comparison
Compare SHREEGANES with any stock or ETFCompare SHREEGANES with any stock or ETF
SHREEGANES
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SHREEGANES has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Earnings
Shree Ganesh Biotech India standalone net profit rises 755.56% in the December 2024 quarter
Net profit of Shree Ganesh Biotech India rose 755.56% to Rs 0.77 crore in the quarter ended December 2024 as against Rs 0.09 crore during the previous quarter ended December 2023. Sales rose 249.76% to Rs 14.41 crore in the quarter ended December 2024 as against Rs 4.12 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales14.414.12 250 OPM %3.262.18 - PBDT0.770.09 756 PBT0.770.09 756 NP0.770.09 756 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Shree Ganesh Biotech India to discuss results
Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Shree Ganesh Biotech India standalone net profit rises 300.00% in the September 2024 quarter
Net profit of Shree Ganesh Biotech India rose 300.00% to Rs 0.32 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. Sales declined 51.94% to Rs 1.98 crore in the quarter ended September 2024 as against Rs 4.12 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1.984.12 -52 OPM %1.011.94 - PBDT0.320.08 300 PBT0.320.08 300 NP0.320.08 300 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Shree Ganesh Biotech India announces board meeting date
Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Shree Ganesh Biotech India to convene AGM
Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Shree Ganesh Biotech India to conduct AGM
Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Shree Ganesh Biotech India standalone net profit rises 60.00% in the June 2024 quarter
Net profit of Shree Ganesh Biotech India rose 60.00% to Rs 0.24 crore in the quarter ended June 2024 as against Rs 0.15 crore during the previous quarter ended June 2023. Sales declined 56.85% to Rs 3.56 crore in the quarter ended June 2024 as against Rs 8.25 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.568.25 -57 OPM %-3.651.82 - PBDT0.240.15 60 PBT0.240.15 60 NP0.240.15 60 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Shree Ganesh Biotech India to announce Quarterly Result
Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Shree Ganesh Biotech India standalone net profit rises 3366.67% in the March 2022 quarter
2 years agoBusiness Standard
Shree Ganesh Biotech India to consider bonus shares issue, stock surges
3 years agoLivemint
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 29.45%, vs industry avg of 6.38%
Increasing Market Share
Over the last 5 years, market share increased from 0.03% to 0.06%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -18.85%, vs industry avg of 4.69%